Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

Grants

Funding Acknowledgements

Grant sponsor: European Community's Seventh Framework Programme; Grant numbers: HEALTH-F2-2009-223175; Grant sponsor: Cancer Research UK; Grant numbers: C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007 and C5047/A10692; Grant sponsor: National Institutes of Health (NIH); Grant numbers: CA128978; Grant sponsor: Post-Cancer GWAS initiative; Grant numbers: 1U19 CA148537, 1U19 CA148065 and 1U19 CA148112; Grant sponsor: the Department of Defence; Grant numbers: W81XWH-10-1-0341; Grant sponsor: Canadian Institutes of Health Research (CIHR); Grant sponsor: Komen Foundation for the Cure; Grant sponsor: the Breast Cancer Research Foundation; Grant sponsor: Ovarian Cancer Research Fund; Grant sponsor: United States National Cancer Institute; Grant sponsor: National Institutes of Health (NIH); Grant numbers: RFA-CA-06-503; Grant sponsor: Breast Cancer Family Registry (BCFR); Grant sponsor: Cancer Care Ontario; Grant numbers: U01 CA69467; Grant sponsor: Cancer Prevention Institute of California; Grant numbers: U01 CA69417; Grant sponsor: University of Melbourne; Grant numbers: U01 CA69638; Grant sponsor: National Health and Medical Research Council of Australia; Grant sponsor: New South Wales Cancer Council; Grant sponsor: Victorian Health Promotion Foundation (Australia); Grant sponsor: Victorian Breast Cancer Research Consortium; Grant sponsor: Dutch Cancer Society; Grant numbers: NKI2007-3839; Grant sponsor: Dutch government (NWO 184.021.007); Grant sponsor: Dutch Cancer Society; Grant numbers: NKI2009-4363; Grant sponsor: ELAN-Program of the University Hospital of Erlangen; Grant sponsor: FIS, Accion Estrategica de Salud del Instituto de Salud Carlos III; Grant numbers: PI12/02125 and PI13/01136; Grant sponsor: KAU; Grant numbers: 1-117-1434-HiCi; Grant sponsor: Botin Foundation's Fund; Grant sponsor: Programa Grupos Emergentes; Cancer Genetics Unit, CHUVI Vigo Hospital, Instituto de Salud Carlos III, Spain; Grant sponsor: Conselleria de Industria Programa Sectorial de Investigacion Aplicada; Grant sponsor: PEME I+D e I+D Suma del Plan Gallego de Investigacion; Grant sponsor: Desarrollo e Innovacion Tecnologica de la Conselleria de Industria de la Xunta de Galicia, Spain; Grant numbers: 10CSA012E; Grant sponsor: Fomento de la Investigacion Clinica Independiente, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain; Grant numbers: EC11-192; Grant sponsor: Grant FEDER-Innterconecta.r Ministerio de Economia y Competitividad, Xunta de Galicia, Spain; Grant sponsor: Fondation de France; Grant sponsor: French National Institute of Cancer (INCa); Grant sponsor: The National League against Cancer; Grant sponsor: National Agency for Environmental and Occupational Health and Food Safety (ANSES); Grant sponsor: National Agency for Research (ANR); Grant sponsor: Association for Research against Cancer (ARC); Grant sponsor: Chief Physician Johan Boserup and Lise Boserup Fund; Grant sponsor: the Danish Medical Research Council; Grant sponsor: Herlev Hospital; Grant sponsor: Genome Spain Foundation; Grant sponsor: Red Tematica de Investigacion Cooperativa en Cancer; Grant sponsor: Asociacion Espanola Contra el Cancer; Grant sponsor: Fondo de Investigacion Sanitario; Grant numbers: PI11/00923 and PI081120; Grant sponsor: Instituto de Salud Carlos III; Grant sponsor: Baden-Wurttemberg State Ministry of Science, Research and Arts; Grant sponsor: German Federal Ministry of Education and Research; Grant sponsor: German Cancer Aid (Deutsche Krebshilfe); Grant sponsor: Federal Ministry of Education and Research (BMBF) Germany; Grant numbers: 01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114, 01KH0401, 01KH0410 and 01KH0411; Grant sponsor: Robert Bosch Foundation, Stuttgart; Grant sponsor: Deutsches Krebsforschungszentrum (DKFZ), Heidelberg; Grant sponsor: Institute for Prevention and Occupational Medicine of the German Social Accident Insurance; Institute of the Ruhr University (IPA), Bochum; Grant sponsor: Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany; Grant sponsor: EVO, Kuopio University Hospital grants; Grant sponsor: Cancer Fund of North Savo; Grant sponsor: Finnish Cancer Organizations; Grant sponsor: Academy of Finland; Grant sponsor: University of Eastern Finland; Grant sponsor: National Breast Cancer Foundation; Grant sponsor: National Health and Medical Research Council (NHMRC); Grant sponsor: Queensland Cancer Fund; Grant sponsor: Cancer Councils of New South Wales, Victoria, Tasmania and South Australia; Grant sponsor: Cancer Foundation of Western Australia; Grant sponsor: US Army Medical Research and Materiel Command; Grant numbers: DAMD 170110729 and W81XWH0610220; Grant sponsor: Stichting tegen Kanker; Grant numbers: 232-2008 and 196-2010; Grant sponsor: NCI; Grant numbers: P50 CA116201 and NIH R01 CA128978; Grant sponsor: Breast Cancer Research Foundation; Grant sponsor: Deutsche Krebshilfe e.V.; Grant numbers: 70-2892-BR I; Grant sponsor: Hamburg Cancer Society; Grant sponsor: German Cancer Research Center; Grant sponsor: Federal Ministry of Education and Research (BMBF), Germany; Grant numbers: 01KH0402; Grant sponsor: VicHealth; Grant sponsor: Cancer Council Victoria; Grant sponsor: Australian NHMRC; Grant numbers: 209057, 251553 and 504711; Grant sponsor: National Cancer Institute; Grant numbers: UM1 CA164920; Grant sponsor: Intramural Research Funds of the National Cancer Institute; Department of Health and Human Services, USA; Grant sponsor: Marit and Hans Rausings Initiative Against Breast Cancer; Grant sponsor: Cancer Risk Prediction Center (CRisP); Grant sponsor: Linnaeus Centre; Grant numbers: 70867902; Grant sponsor: Agency for Science, Technology and Research of Singapore (A<SUP>star</SUP>STAR); Grant sponsor: US National Institute of Health (NIH); Grant sponsor: Susan G.r Komen Breast Cancer Foundation; Grant sponsor: Swedish Cancer Society; Grant numbers: 5128-B07-01PAF; Grant sponsor: Yorkshire Cancer Research; Grant numbers: S305PA; Grant sponsor: Cancer Research, UK; Grant numbers: C490/A10124; Grant sponsor: UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; Grant sponsor: Breakthrough Breast Cancer and the Institute of Cancer Research (ICR); Grant sponsor: NHS; Grant sponsor: NIHR Biomedical Research Centre.